Obvious Technology Inc. develops AiBlock™, a unit of intelligent function based on enterprise-ready frameworks. It supports diverse business needs through proprietary algorithms and technologies such as Computer Vision, Natural Language Processing, Machine Learning, and Deep Learning.

Obvious Technology Inc.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Metric
Company Name	Obvious Technology Inc.	InspireMD, Inc.
Symbol		NSPR
MSH ID	AI:OBVS	COM:INSPIREMD
Market	PRIVATE	STOCKS
Sector	Technology	Healthcare
Industry	Software & AI	Medical - Devices
Country	US	IL
Stage	Pre Seed
Employee Count		68
Website	obvs.ai	inspiremd.com
LinkedIn
Founders

Metric
Market Cap		61.65M
Enterprise Value
Monthly Web Traffic	11.93K
Web Traffic Growth	0.94
Valuation
Raised Capital

Metric
Revenue		6.21M
Revenue (LTM)
Revenue (NTM)
Gross Profit		1.81M
EBITDA		-20.66M
Operating Income		-20.89M
Net Income		-19.92M
EPS		-0.82
Diluted EPS		-0.82
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.29
Operating Profit Margin		-3.41
EBITDA Margin		-3.33
Net Profit Margin		-2.63
Return on Equity		-0.55
Return on Assets		-0.31
Return on Capital Employed		-0.49

AI:OBVS

Obvious Technology Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-4.86
P/B Ratio		2.16
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		13.06
EV Multiple		-2.56

Metric
Days Sales Outstanding		93.95
Days Payables Outstanding		55.16
Days Inventory Outstanding		181.31
Operating Cycle		319.02
Cash Conversion Cycle		241.09
Asset Turnover		0.15

Metric
Operating Cash Flow		-16.38M
Free Cash Flow		-16.76M
Cash Flow to Debt
Operating Cash Flow/Sales		-2.02
Free Cash Flow Yield		-0.26

Metric
Cash & Equivalents		9.64M
Accounts Receivable		-1.21M
Inventory		2.11M
Goodwill
Debt to Capitalization		0.04
Debt to Assets		0.03
Current Ratio		9.96
Quick Ratio		7.41

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.59
R&D to Revenue		1.46
SG&A to Revenue		1.86